Mizuho Forecasts Strong Price Appreciation for Harmony Biosciences (NASDAQ:HRMY) Stock
Harmony Biosciences (NASDAQ:HRMY – Free Report) had its target price raised by Mizuho from $44.00 to $48.00 in a research report sent to investors on Thursday morning,Benzinga reports. Mizuho currently has an outperform rating on the stock. HRMY has been the topic of a number of other research reports. HC Wainwright restated a “buy” rating […]
Harmony Biosciences (NASDAQ:HRMY – Free Report) had its target price raised by Mizuho from $44.00 to $48.00 in a research report sent to investors on Thursday morning,Benzinga reports. Mizuho currently has an outperform rating on the stock. HRMY has been the topic of a number of other research reports. HC Wainwright restated a “buy” rating […]
